Apogee Therapeutics CFO Jane Henderson disposes 2,000 shares worth $180,000

• Apogee Therapeutics CFO Jane Pritchett Henderson sold 2,000 common shares on April 16, 2026 at USD 90 per share.
• Holdings fell to 175,371 common shares following transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-045062), on April 17, 2026, and is solely responsible for the information contained therein.